RenovoRx, Inc. Common Stock (NASDAQ: RNXT) last traded at $1.32, up 0.00% on the session. The quote above updates while this page is open; the figures below are drawn from RenovoRx, Inc. Common Stock’s own filings and are restated only when a new one is published.
RenovoRx, Inc. Common Stock trades on NASDAQ under the ticker RNXT. Its market capitalisation is $59.57 million.
Valuation measures for RenovoRx, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $59.57M |
|---|---|
| Enterprise value | $52.58M |
| Price / sales | 30.15 |
| Price / book | 6.63 |
| Beta | 1.40 |
Trailing-twelve-month figures tagged in RenovoRx, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $1.98M |
|---|---|
| Net income (TTM) | -$12.29M |
| EPS (TTM) | -$0.310 |
| Gross margin | 84.41% |
| Operating margin | -685.22% |
| Return on equity | -136.82% |
| Cash | $9.48M |
Range and volume for RNXT over the past 52 weeks.
| 52-week high | $1.51 |
|---|---|
| 52-week low | $0.701 |
| Volume | 233.1K |
| Average volume | 326.5K |
| Previous close | $1.32 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.